tiprankstipranks
NextCell Pharma AB (SE:NXTCL)
:NXTCL
Sweden Market
Want to see SE:NXTCL full AI Analyst Report?

NextCell Pharma AB (NXTCL) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
NextCell Pharma AB’s (NXTCL) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting NextCell Pharma AB is a Buy.
NextCell Pharma AB’s (NXTCL) 20-Day exponential moving average is 1.13, while NextCell Pharma AB’s (NXTCL) share price is kr0.92, making it a Sell.
NextCell Pharma AB’s (NXTCL) 50-Day exponential moving average is 1.18, while NextCell Pharma AB’s (NXTCL) share price is kr0.92, making it a Sell.

NextCell Pharma AB (NXTCL) Pivot Points

Jun 13, 2026, 12:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.95
0.99
1.02
1.06
1.09
1.13
1.16
Fibonacci
0.99
1.02
1.03
1.06
1.09
1.10
1.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NextCell Pharma AB (NXTCL) Moving Averages

Jun 13, 2026, 12:38 PM
Period
Simple
Exponential
MA5
1.07Sell
1.08Sell
MA10
1.10Sell
1.10Sell
MA20
1.15Sell
1.13Sell
MA50
1.19Sell
1.18Sell
MA100
1.29Sell
1.18Sell
MA200
1.09Sell
1.11Sell
NextCell Pharma AB’s (NXTCL) 10-Day exponential moving average is 1.10, while NextCell Pharma AB’s (NXTCL) share price is kr0.92, making it a Sell.
NextCell Pharma AB’s (NXTCL) 100-Day exponential moving average is 1.18, while NextCell Pharma AB’s (NXTCL) share price is kr0.92, making it a Sell.
NextCell Pharma AB’s (NXTCL) stock price is kr0.92 and NextCell Pharma AB’s (NXTCL) 50-day simple moving average is 1.19, creating a Sell signal.
NextCell Pharma AB’s (NXTCL) stock price is kr0.92 and NextCell Pharma AB’s (NXTCL) 100-day simple moving average is 1.29, creating a Sell signal.
NextCell Pharma AB’s (NXTCL) stock price is kr0.92 and NextCell Pharma AB’s (NXTCL) 200-day simple moving average is 1.09, creating a Sell signal.

NextCell Pharma AB (NXTCL) Technical Indicators

Jun 13, 2026, 12:38 PM
Name
Value
Implied Action
RSI (14)
40.93
Neutral
STOCH (9,6)
19.01
Buy
STOCHRSI (14)
13.98
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
14.29
Buy
Williams %R
-84.96
Buy
CCI (14)
-113.49
Buy
ATR (14)
0.08
-
Ultimate Oscillator
56.21
Neutral
ROC
-16.40
Sell
NextCell Pharma AB’s (NXTCL) Relative Strength Index (RSI) is 40.93, creating a Neutral signal.
NextCell Pharma AB’s (NXTCL) Trend Strength Indicator (ADX) is 14.29, creating a Buy signal.
NextCell Pharma AB’s (NXTCL) Commodity Channel Index (CCI) is -113.49, creating a Buy signal.
NextCell Pharma AB’s (NXTCL) Price Rate of Change (ROC) is -16.40, creating a Sell signal.

FAQ

Is NXTCL a Buy, Hold, or Sell?
Based on NXTCL’s technical indicators, NXTCL is a Sell.
    What is NXTCL’s RSI (14)?
    NXTCL’s RSI (14) is 40.93, which suggests NXTCL is a Neutral.
      What is NXTCL’s MACD?
      NXTCL’s MACD is -0.03, which suggests NXTCL is a Buy.
        What is NXTCL’s 5-day moving average?
        NXTCL’s 5-day moving average is 1.07, which suggests NXTCL is a Sell.
          What is NXTCL’s 20-day moving average?
          NXTCL 20-day moving average is 1.15, which suggests NXTCL is a Sell.
            What is NXTCL’s 50-day moving average?
            NXTCL’s 50-day moving average is 1.19, which suggests NXTCL is a Sell.
              What is NXTCL’s 200-day moving average?
              NXTCL’s 200-day moving average is 1.09, which suggests NXTCL is a Sell.
                What is NXTCL’s Williams % R (14)?
                NXTCL’s Williams % R (14) is -84.96, which suggests NXTCL is a Buy.
                  What is NXTCL’s CCI (14)?
                  NXTCL’s CCI (14) is -113.49, which suggests NXTCL is a Buy.
                    What is the share price of NextCell Pharma AB?